| Business Combination, Contingent Consideration [Table Text Block] |
Common Stock - 38,308 shares issued | | $ | 660,805 | |
Common Stock - 3,927 shares withheld | | | 67,742 | |
Earnout liabilities | | | 301,633 | |
Estimated costs related to acquisition | | | 150,000 | |
Total estimated value of consideration transferred | | $ | 1,180,180 | |
|
| Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] |
Accounts receivable | | $ | 76,555 | |
Inventory | | | 1,286,139 | |
Prepaid expenses and deposits | | | 94,567 | |
Right of use asset | | | 51,721 | |
Property and equipment | | | 47,618 | |
Total assets | | | 1,556,600 | |
Accounts payable | | | 309,974 | |
Customer deposits | | | 13,806 | |
Operating lease liability | | | 52,640 | |
Net assets to be acquired | | $ | 1,180,180 | |
|
| Business Combination, Pro Forma Information [Table Text Block] |
| | Three months ended June 30, | | | Six Months Ended June 30, | |
| | 2026 | | | 2025 | | | 2026 | | | 2025 | |
Net sales from the unaudited condensed consolidated statements of operations | | $ | 395,991 | | | $ | 503,612 | | | $ | 787,755 | | | $ | 1,013,965 | |
Add: Elevai Skincare net sales not reflected in the unaudited condensed consolidated statements of operations | | | — | | | | — | | | | — | | | | 152,381 | |
Unaudited pro forma net sales | | $ | 395,991 | | | $ | 503,612 | | | $ | 787,755 | | | $ | 1,166,346 | |
| | | | | | | | | | | | | | | | |
Net loss from the unaudited condensed consolidated statements of operations | | $ | (1,883,290 | ) | | $ | (1,886,438 | ) | | $ | (3,315,003 | ) | | $ | (3,392,305 | ) |
Add: Inventory step-up adjustment recognized in cost of sales | | | — | | | | 151,689 | | | | — | | | | 386,341 | |
Add: Elevai Skincare net loss not reflected in the unaudited condensed consolidated statements of operations | | | — | | | | — | | | | — | | | | (27,644 | ) |
Unaudited pro forma net loss | | $ | (1,883,290 | ) | | $ | (1,734,749 | ) | | $ | (3,315,003 | ) | | $ | (3,033,608 | ) |
|